Sebastien Morin Email and Phone Number

www.immex.ca

• Secure input from all relevant Canadian personnel and provide input on clinical, competition, KOL management, market development and understanding, medical, regulatory/legal and reimbursement/outcomes research (OR) requests from Global for new products in pre-clinical to phase 3 in Bone, Cardiovascular (CV), Diabetes, Dermatology, Immunology, Infectious Disease, Merck Bioventures, Neuroscience, Respiratory and Women's Health. • Manage and lead new products local activities and projects… Show more • Secure input from all relevant Canadian personnel and provide input on clinical, competition, KOL management, market development and understanding, medical, regulatory/legal and reimbursement/outcomes research (OR) requests from Global for new products in pre-clinical to phase 3 in Bone, Cardiovascular (CV), Diabetes, Dermatology, Immunology, Infectious Disease, Merck Bioventures, Neuroscience, Respiratory and Women's Health. • Manage and lead new products local activities and projects until filing to Health Canada (i.e. develop, implement and monitor the pre-launch commercial planning strategy, forecast, plan and manage expenses, market research, market access/OR, consultations, KOLs management, grants/sponsorships, CME, public affairs…).• Point person for the EUCAN region for new CV products (vorapaxar, betrixaban, anti-PCSK9 mAB, anti-hypertensive products…) • As a member of the Global Brand Team core group for vorapaxar, participated and contributed to the US and Global positioning workshops and many other meetings to prepare the Global launch. Show less

• Provided direction and coaching and managed, evaluated and recruited a group of 9 CVM MSLs. • Developed and maintained the Country Integrated Medical Scientific Strategy for atherosclerosis, diabetes and heart failure and provided scientific strategic input on current and future molecules. • Increased awareness, endorsement and access to the market for TREDAPTIVE, COZAAR/HYZAAR, rolofylline and JANUVIA/JANUMET by developing, implementing and monitoring the tactical plans. •… Show more • Provided direction and coaching and managed, evaluated and recruited a group of 9 CVM MSLs. • Developed and maintained the Country Integrated Medical Scientific Strategy for atherosclerosis, diabetes and heart failure and provided scientific strategic input on current and future molecules. • Increased awareness, endorsement and access to the market for TREDAPTIVE, COZAAR/HYZAAR, rolofylline and JANUVIA/JANUMET by developing, implementing and monitoring the tactical plans. • Provided feedback and input to internal stakeholders during the commercial planning process and recommended the appropriate resources and the necessary changes to accomplish the objectives.• Acted as the key scientific expert in atherosclerosis, heart failure (HF), hypertension and diabetes and provided scientific support to internal stakeholders to ensure scientific validity and credibility. • Conducted advisory boards/consultations meetings in collaboration with marketing. • Worked with medical and clinical research personnel to identify potential investigators for phases 1, 2 and 3 clinical research projects and secured and monitored their participation. • Collaborated with and maintained ongoing scientific partnerships with top Canadian KOLs and other external stakeholders in the development of scientific strategic initiatives and projects. • Fully integrated with local, regional and national medical and other HCP societies and associations. Show less

• Assisted the development of the marketing strategy and many promotional materials for INEGY and EZETROL.• Assisted on market research and outcomes research projects, KOL management, advisory board meetings, public affairs initiatives, and medical/legal approval processes.• Assisted on medical affairs/clinical studies projects and provided comments on many scientitic articles, research projects and documents prepared by the global Medical Director.• Worked with global eMarketing… Show more • Assisted the development of the marketing strategy and many promotional materials for INEGY and EZETROL.• Assisted on market research and outcomes research projects, KOL management, advisory board meetings, public affairs initiatives, and medical/legal approval processes.• Assisted on medical affairs/clinical studies projects and provided comments on many scientitic articles, research projects and documents prepared by the global Medical Director.• Worked with global eMarketing and lead the updates of INEGY and EZETROL Websites, the update and optimization of the e-learning tool, and the development of the ENHANCE Website.• Assisted the development of the 2008 annual plan for INEGY and EZETROL. • Assisted the planning of activities (i.e. symposiums, exhibits, expert input forums (EIF), newsletters) at key congresses (ACC, EAS, ESC and EASD), Free Standing Symposium (FSS) and Speaker's Forum.• Gained knowledge of the European, Middle-Eastern and African (EMEA) environment by participating and presenting at many meetings with the Merck and Schering-Plough teams and at a Merck European MarketingTeam (EMT) meeting. Show less

• Established and maintained highly effective contact and rapport with the atherosclerosis academic and community opinion leaders (OL), both clinicians and basic scientists, in the Province of Quebec. • Created early awareness and acceptance of the scientific evidence included in the EZETROL scientific strategy platform and provided relevant scientific information to KOLs involved in formulary listings, treatment guidelines and public health programs. • Provided scientific support (i.e.… Show more • Established and maintained highly effective contact and rapport with the atherosclerosis academic and community opinion leaders (OL), both clinicians and basic scientists, in the Province of Quebec. • Created early awareness and acceptance of the scientific evidence included in the EZETROL scientific strategy platform and provided relevant scientific information to KOLs involved in formulary listings, treatment guidelines and public health programs. • Provided scientific support (i.e. articles, abstracts, slides…) to speakers used by sales. • Supported and developed hospital rounds, distinguished speaker lecture series and other education programs, designed to transfer information to KOLs at the highest scientific levels. • Identified opportunities for Investigator Initiated Study Proposals and secured and monitored the investigators' participation. • Worked to support the content & positioning of EZETROL within the 2006 Canadian lipid guidelines.• Encouraged and facilitated three publications of articles supporting EZETROL by Drs Genest and Levy and by Jean Lefebvre, a pharmacist. Show less

• Lead the development and communicated forecasts for FOSAMAX in support of monthly demand meetings, profit plan, long-range operating plan and 10-year outlook processes. • Managed primary and secondary research activities for EMEND and the Internet teams. • Developed the CI specialist role and turned the position into an important contributor to marketing, sales and the company as a whole.• Learned about competitive war-games and prepared, organized and conducted many strategic and… Show more • Lead the development and communicated forecasts for FOSAMAX in support of monthly demand meetings, profit plan, long-range operating plan and 10-year outlook processes. • Managed primary and secondary research activities for EMEND and the Internet teams. • Developed the CI specialist role and turned the position into an important contributor to marketing, sales and the company as a whole.• Learned about competitive war-games and prepared, organized and conducted many strategic and tactical war games with sales and marketing. • Prepared, forecasted and presented to EOC members an outlook of the Canadian industry to 2007. Show less